Rice, Texas Heart Institute scientists model how synthetic gels can tune body’s inflammatory response
Rice researchers and collaborators at Texas Heart Institute (THI) have established a baseline set of injectable hydrogels that promise to help heal wounds, deliver drugs and treat cancer. Critically, they’ve analyzed how the chemically distinct hydrogels provoke the body’s inflammatory response — or not.
Hydrogels developed at Rice are designed to be injectable and create a mimic of cellular scaffolds in a desired location. They serve as placeholders while the body naturally feeds new blood vessels and cells into the scaffold, which degrades over time to leave natural tissue in its place. Hydrogels can also carry chemical or biological prompts that determine the scaffold’s structure or affinity to the surrounding tissue.
The study led by chemist and bioengineer Jeffrey Hartgerink and graduate student Tania Lopez-Silva at Rice and Darren Woodside, vice president for research and director of the flow cytometry and imaging core at THI, demonstrates it should be possible to tune multidomain peptide hydrogels to produce appropriate inflammatory response for what they’re treating.
The research appears in Biomaterials.
“We’ve been working on peptide-based hydrogels for a number of years and have produced about 100 different types,” Hartgerink said. “In this paper, we wanted to back up a bit and understand some of the fundamental ways in which they modify biological environments.”
The researchers wanted to know specifically how synthetic hydrogels influence the environment’s inflammatory response. The two-year study offered the first opportunity to test a variety of biocompatible hydrogels for the levels of inflammatory response they trigger.
“Usually, we think of inflammation as bad,” Hartgerink said. “That’s because inflammation is sometimes associated with pain, and nobody likes pain. But the inflammatory response is also extremely important for wound healing and in clearing infection.
“We don’t want zero inflammation; we want appropriate inflammation,” he said. “If we want to heal wounds, inflammation is good because it starts the process of rebuilding vasculature. It recruits all kinds of cells that are regenerative to that site.
The labs tested four basic hydrogel types — two with positive charge and two negative — to see what kind of inflammation they would trigger. They discovered that positively charged hydrogels triggered a much stronger inflammatory response than negatively charged ones.
“Among the positive materials, depending on the chemistry generating that charge, we can either generate a strong or a moderate inflammatory response,” Hartgerink said. “If you’re going for wound-healing, you really want a moderate response, and we saw that in one of the four materials.
“But if you want to go for a cancer treatment, the higher inflammatory response might be more effective,” he said. “For something like drug delivery, where inflammation is not helpful, one of the negatively charged materials might be better.
“Basically, we’re laying the groundwork to understand how to develop materials around the inflammatory responses these materials provoke. That will give us our best chance of success.”
The THI team helped analyze the cellular response to the hydrogels through multidimensional flow cytometry.
“The results of this work lay the groundwork for specifically tailoring delivery of a therapeutic by a delivery vehicle that is functionally relevant and predictable,” Woodside said. “Aside from delivering drugs, these hydrogels are also compatible with a variety of cell types.
“One of the problems with stem cell therapies at present is that adoptively transferred cells don’t necessarily stay in high numbers at the site of injection,” he said. “Mixing these relatively inert, negatively charged hydrogels with stem cells before injection may overcome this limitation.”
Hartgerink said the work is foundational, rather than geared toward a specific application, but is important to the long-term goal of bringing synthetic hydrogels to the clinic. “We have been speculating about a lot of the things we think are good and true about this material, and we now have more of a sound mechanistic understanding of why they are, in fact, true,” Hartgerink said.
Learn more: Hydrogels control inflammation to help healing
Go deeper with Bing News on:
Hydrogels to control inflammation
- Anti-Inflammatory Drugs Market to Exhibit 9.3% CAGR by 2027 Owing to Rising Prevalence of Inflammatory Health Conditions: Fortune Business Insights™on August 20, 2021 at 4:39 am
and others are the major anti-inflammatory drugs market growth driver. As per the Centers for Disease Control and Prevention, an estimate of 78 million people in the U.S. will be diagnosed with ...
- Hidradenitis suppurativa: Discontinuation of adalimumab prior to surgery is not necessaryon August 18, 2021 at 5:00 pm
Acneinversa) is one of the most troublesome and complicated skin diseases. The anti-inflammatory drug adalimumab can improve symptoms; however, patients also often have to undergo surgery.
- Disorders and Syndromes Newson August 10, 2021 at 4:59 pm
Aug. 10, 2021 — Beige is considered a calming paint color, and scientists have new evidence that beige fat has a similar impact on the brain, bringing down the inflammation associated with the ...
- Fears Covid could trigger diabetes surge in Indiaon August 10, 2021 at 4:37 pm
Steroids reduce inflammation in the lungs for Covid-19 and appear to ... Nearly a year after recovery, Mr Shah, 47, is still on medication to control his blood sugar. "I know a lot of people like me ...
- Ocular Therapeutix, Inc. (OCUL) CEO Antony Mattessich on Q2 2021 Results - Earnings Call Transcripton August 9, 2021 at 6:22 pm
And finally, to DEXTENZA that we believe fulfills the patient and physician desires to have a more convenient drop-free solution for the treatment of post-surgical inflammation and pain.
Go deeper with Google Headlines on:
Hydrogels to control inflammation
Go deeper with Bing News on:
- COVID-19: Rare inflammatory syndrome in children examined in new studyon August 20, 2021 at 5:10 am
A study presents the first genome-wide study to investigate a rare but severe inflammatory syndrome in children following SARS-CoV-2 infection.
- WVU researcher investigates inflammatory responses produced by exposure to chemical agentson August 18, 2021 at 5:54 pm
Many of us face safety risks at work, but those serving in the military or working in law enforcement and industrial settings are at greater risk for dangerous chemical exposures.
- WVU researcher studies inflammatory effects of toxic chemicalson August 18, 2021 at 2:13 pm
People who serve in the military or work in law enforcement and industrial settings are at greater risk for dangerous chemical exposures. Jonathan Boyd, a researcher in West Virginia University's ...
- Histamine may be a missing link connecting inflammation and depressionon August 17, 2021 at 9:55 pm
Through a series of ingenious mouse experiments researchers have discovered evidence that inflammation-induced histamine activity can inhibit the release of serotonin in the brain. The findings ...
- Researchers Discover On/Off Switch for Inflammatory Painon August 16, 2021 at 8:37 am
Chavan, Ph.D., professor in the Institute of Bioelectronic Medicine, and associated professor Huan Yang Ph.D., combines optogenetics, neuronal-specific deletion, and preclinical models of inflammatory ...